pyrazole has been researched along with ascorbic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berl, L; Cederbaum, AI | 1 |
Córdoba, F; Crane, FL; Navas, P; Santos-Ocaña, C | 1 |
Che, CM; Chui, SS; Lau, TC; Ng, MF; Shek, L; Sun, RW; Wong, EL; Zhang, J | 1 |
3 other study(ies) available for pyrazole and ascorbic acid
Article | Year |
---|---|
Pyrazole and 4-methylpyrazole inhibit oxidation of ethanol and dimethyl sulfoxide by hydroxyl radicals generated from ascorbate, xanthine oxidase, and rat liver microsomes.
Topics: Animals; Ascorbic Acid; Dimethyl Sulfoxide; Ethanol; Fomepizole; Free Radicals; Hydroxides; Hydroxyl Radical; Kinetics; Male; Microsomes, Liver; Oxidation-Reduction; Pyrazoles; Rats; Rats, Inbred Strains; Xanthine Oxidase | 1982 |
Extracellular ascorbate stabilization as a result of transplasma electron transfer in Saccharomyces cerevisiae.
Topics: Ascorbic Acid; Cell Membrane; Chloroquine; Electron Transport; Enzyme Inhibitors; Ethanol; Ferricyanides; Kinetics; NAD; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Pyrazoles; Saccharomyces cerevisiae; Sulfhydryl Reagents; Ubiquinone | 1995 |
Dual anti-angiogenic and cytotoxic properties of ruthenium(III) complexes containing pyrazolato and/or pyrazole ligands.
Topics: Angiogenesis Inhibitors; Apoptosis; Ascorbic Acid; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Ligands; Molecular Conformation; Pyrazoles; Ruthenium | 2009 |